NCT05861947View on ClinicalTrials.gov

A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 26, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung CancerGastric CancerUrothelial CarcinomaKidney CancerColon CancerEsophagus Cancer
Interventions
DRUG

AUR106

Once or twice daily

Trial Locations (6)

395002

RECRUITING

Unique Hospital Multispeciality and Research Institute, Surat

395004

RECRUITING

Kiran Multi Super Specialty Hospital, Surat

411033

NOT_YET_RECRUITING

Moraya Multispeciality Hospital (Ashwin Medical Foundations), Pune

422009

RECRUITING

Sankalp Speciality Hospital, Nashik

530040

RECRUITING

Omega Hospital, Visakhapatnam

751019

RECRUITING

All India Institute of Medical Sciences, Bhubaneswar

Sponsors
All Listed Sponsors
lead

Aurigene Discovery Technologies Limited

INDUSTRY